HCPCS Codes Similar to M1174

HCPCS Codes Similar to “M1174” Code.
Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period

M1176 Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period Code added date: 20230101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON	M1238 Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31) Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
G2160 Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G2162 Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON
G2161 Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	M1175 Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine) Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
G2157 Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G9246 Patient did not have two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart Code added date: 20140101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
G9247 Patient had two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart Code added date: 20140101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	G2159 Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON
G9349 Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis Code added date: 20140101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON	G9350 Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis Code added date: 20140101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON
M1468 Patient received recommended doses of hepatitis b vaccination based on age Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON	M1472 Patient did not receive recommended doses of hepatitis b vaccination based on age Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON